Li Albert S, Shih Carolyn Y, Rosen Lisa, Steiner Anne, Milman Tatyana, Udell Ira J
Department of Ophthalmology, North Shore Long Island Jewish Health System, Great Neck, New York.
Department of Ophthalmology, North Shore Long Island Jewish Health System, Great Neck, New York.
Am J Ophthalmol. 2015 Aug;160(2):213-219.e1. doi: 10.1016/j.ajo.2015.04.027. Epub 2015 Apr 24.
To evaluate the recurrence rate of ocular surface squamous neoplasias (OSSN) after excision and cryotherapy in an academic cornea practice and to determine factors associated with recurrence.
Retrospective interventional case series.
All cases of OSSN from 1998 through 2013 that were treated with excisional biopsy and adjunctive cryotherapy were retrospectively reviewed. Clinical characteristics upon presentation including size of lesion, location, and atypical features were noted. All recurrences of OSSN after excision and cryotherapy were noted and categorized in relation to clinical characteristics, pathologic grade, and margin involvement.
Forty-three cases of OSSN from 42 patients were analyzed with a median follow-up of 29 months. A total of 32.6% of subjects had dysplasia and 67.4% had squamous cell carcinoma (SCC). A total of 83.7% of subjects had both corneal and conjunctival involvement while 16.3% had conjunctival involvement only. Overall, 3 recurrences were observed, all of which had margin involvement; nonetheless, the majority of incompletely excised OSSN (25/28) showed no recurrence. The recurrence rate at 6 months was 2.3%. Recurrence at 1 year, 2 years, and 5 years remained stable at 7.1%.
Excision with cryotherapy is an effective treatment for the majority of OSSN cases, even among cases with pathologic evidence of tumor at the margin, with an overall recurrence rate of 7.1% at 1 year, 2 years, and 5 years.
在学术性角膜诊疗实践中评估眼表鳞状上皮肿瘤(OSSN)切除联合冷冻治疗后的复发率,并确定与复发相关的因素。
回顾性干预性病例系列研究。
对1998年至2013年期间所有接受切除活检及辅助冷冻治疗的OSSN病例进行回顾性分析。记录初诊时的临床特征,包括病变大小、位置及非典型特征。记录OSSN切除联合冷冻治疗后的所有复发情况,并根据临床特征、病理分级及切缘受累情况进行分类。
分析了42例患者的43例OSSN病例,中位随访时间为29个月。共有32.6%的患者为发育异常,67.4%为鳞状细胞癌(SCC)。共有83.7%的患者角膜和结膜均受累,16.3%仅结膜受累。总体而言,观察到3例复发,均有切缘受累;然而,大多数切除不完全的OSSN(25/28)未复发。6个月时的复发率为2.3%。1年、2年和5年的复发率保持稳定,均为7.1%。
切除联合冷冻治疗对大多数OSSN病例有效,即使是切缘有肿瘤病理证据的病例,1年、2年和5年的总体复发率为7.1%。